COLL · Collegium Pharmaceutical, Inc · Debt
$23.59
+0.67 (+2.92%)
At close · Oct 22
Return incl. dividend (before tax)
Market Cap
$746.01M
Shares
32.56M
Volume · Oct 22
203.15K
Avg daily vol (3M)
781.51K
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-06-30 | USD 1,561,000 | 10-Q filed 2026-08-06 |
| Current portion of loans payable | 2026-06-30 | USD 55,000,000 | 10-Q filed 2026-08-06 |
| Noncurrent convertible notes payable | 2026-06-30 | USD 238,733,000 | 10-Q filed 2026-08-06 |
| Noncurrent loans payable | 2026-06-30 | USD 797,824,000 | 10-Q filed 2026-08-06 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 3,407,000 | 10-Q filed 2026-08-06 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1267565
CUSIP
19459J104
13F (30d)
22 filings
22 filers
Visit website
Investor relations